Search results: Sage Journals

Restricted accessReview articleFirst published September, 2025

A Review on the Mechanisms and Clinical Advances of JAK Inhibitors in the Treatment of Rosacea

Yulian Hu, Biyu Li, Runlu Hu [...]

Journal of Cutaneous Medicine and Surgery

Free accessReview articleFirst published August, 2011

JAK inhibitors and other novel agents in myeloproliferative neoplasms: are we hitting the target?

Nicole Kucine, Ross L. Levine

Therapeutic Advances in Hematology

Restricted accessReview articleFirst published March, 2023

JAK inhibitors for the treatment of VEXAS syndrome

Sara Bindoli, Chiara Baggio, Andrea Doria [...]

Experimental Biology and Medicine

Open accessResearch articleFirst published 2020

JAK inhibitors and infections risk: focus on herpes zoster

Flavia Sunzini, Iain McInnes, Stefan Siebert

Therapeutic Advances in Musculoskeletal Disease

Restricted accessResearch articleFirst published February, 2020

The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib

Wenxia Wang, Swati Bhattacharyya, Roberta Goncalves Marangoni [...]

Journal of Scleroderma and Related Disorders

Open accessReview articleFirst published July, 2021

Role of JAK/STAT in the Neuroinflammation and its Association with Neurological Disorders

Mayank Jain, Mukul Kumar Singh, Hari Shyam [...]

Annals of Neurosciences

Open accessCase reportFirst published 2024

Cutaneous T-cell lymphoma in a JAK inhibitor patient: A case report

Sophy Mo, Dominique Friedmann

Sage Open Medical Case Reports

Open accessReview articleFirst published 2025

JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel disease

Fotios S. Fousekis, André Jefremow, Konstantinos H. Katsanos [...]

Therapeutic Advances in Gastroenterology

Restricted accessResearch articleFirst published January, 2023

Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway

Wei Jing Loo, Irina Turchin, Vimal H. Prajapati [...]

Journal of Cutaneous Medicine and Surgery

Free accessReview articleFirst published October, 2010

JAK/STAT Pathways in Cytokine Signaling and Myeloproliferative Disorders

Shashidhar S. Jatiani, Stacey J. Baker, Lewis R. Silverman [...]

Genes & Cancer

Restricted accessReview articleFirst published September, 2025

A Review on the Mechanisms and Clinical Advances of JAK Inhibitors in the Treatment of Rosacea

Yulian Hu, Biyu Li, Runlu Hu [...]

Journal of Cutaneous Medicine and Surgery

Free accessReview articleFirst published August, 2011

JAK inhibitors and other novel agents in myeloproliferative neoplasms: are we hitting the target?

Nicole Kucine, Ross L. Levine

Therapeutic Advances in Hematology

Restricted accessReview articleFirst published March, 2023

JAK inhibitors for the treatment of VEXAS syndrome

Sara Bindoli, Chiara Baggio, Andrea Doria [...]

Experimental Biology and Medicine

Open accessResearch articleFirst published 2020

JAK inhibitors and infections risk: focus on herpes zoster

Flavia Sunzini, Iain McInnes, Stefan Siebert

Therapeutic Advances in Musculoskeletal Disease

Restricted accessResearch articleFirst published February, 2020

The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib

Wenxia Wang, Swati Bhattacharyya, Roberta Goncalves Marangoni [...]

Journal of Scleroderma and Related Disorders

Open accessReview articleFirst published July, 2021

Role of JAK/STAT in the Neuroinflammation and its Association with Neurological Disorders

Mayank Jain, Mukul Kumar Singh, Hari Shyam [...]

Annals of Neurosciences

Open accessCase reportFirst published 2024

Cutaneous T-cell lymphoma in a JAK inhibitor patient: A case report

Sophy Mo, Dominique Friedmann

Sage Open Medical Case Reports

Open accessReview articleFirst published 2025

JAK inhibitors in the management of extra-intestinal manifestations in inflammatory bowel disease

Fotios S. Fousekis, André Jefremow, Konstantinos H. Katsanos [...]

Therapeutic Advances in Gastroenterology

Restricted accessResearch articleFirst published January, 2023

Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway

Wei Jing Loo, Irina Turchin, Vimal H. Prajapati [...]

Journal of Cutaneous Medicine and Surgery

Free accessReview articleFirst published October, 2010

JAK/STAT Pathways in Cytokine Signaling and Myeloproliferative Disorders

Shashidhar S. Jatiani, Stacey J. Baker, Lewis R. Silverman [...]

Genes & Cancer